Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guilin Tianhe Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacture of external-use traditional Chinese medicine (TCM) and topical analgesic patches. Founded in 1952 and later restructured, the company became a subsidiary of Guilin Sanjin Pharmaceutical in 2004 and is now part of the China Resources Pharmaceutical Group network. Its flagship products, such as the Tianhe Gutong Plaster and Zhuifeng Gao, are market leaders in China for treating orthopedic pain, rheumatism, and muscle injuries. The company operates multiple GMP-certified production lines and maintains a significant presence in both domestic and international markets, exporting to over 30 countries. Tianhe is recognized as a high-tech enterprise with a strong focus on modernizing traditional plaster formulations through advanced transdermal drug delivery technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianhe Pharmaceutical.